The website 'Die Nationale Dekade gegen Krebs' is a German government-backed initiative led by the Bundesministerium für Bildung und Forschung (BMBF) to advance cancer research and support affected individuals. It serves as a comprehensive platform providing information on research projects, patient involvement, partner organizations, and relevant events. The site is professionally designed with excellent content quality, clear navigation, and strong branding consistency. Technically, it uses the Government Site Builder CMS, modern JavaScript libraries like Slick Slider and MediaElement.js, and is hosted by ITZBund, ensuring reliable infrastructure and good performance. Security posture is solid with HTTPS enforced and a cookie consent mechanism that complies with GDPR, although some security headers could be improved. The site uses Matomo analytics with anonymized data collection and explicit user consent, reflecting good privacy practices. No contact emails or phone numbers are explicitly listed, and no terms of service page is found. Overall, the website is trustworthy, secure, and well-aligned with its mission as a national cancer research initiative.
Scanned ·
NIS2 and GDPR posture
GDPR outside view
28/ 100 · High
Checks completed
7of 7
NIS2 Art. 21(2)
a(a) Risk analysis and security policies: Not visible from outside
b(b) Incident handling: One indicator
c(c) Business continuity, backups and crisis management: Not visible from outside
d(d) Supply chain security: Not visible from outside
e(e) Secure acquisition, development and maintenance, including vulnerability handling: Partly checked
f(f) Assessing the effectiveness of security measures: Not visible from outside
g(g) Cyber hygiene and security training: Not visible from outside
h(h) Cryptography and encryption: Partly checked
i(i) HR security, access control and asset management: One indicator
j(j) Multi-factor authentication and secured communications: Not visible from outside
Partly checked
One indicator
Not visible from outside
This scan rated NIS2 with an earlier keyword method that is no longer shown; rescan for the per-article view. Risk management, continuity, supply chain, training, MFA, management oversight (Art. 20) and incident reporting (Art. 23) need internal evidence, and Guard cannot tell whether NIS2 applies to this organisation.
GDPR is indicative only, based on publicly visible signals: Articles 7, 12, 13 and 32 of Regulation (EU) 2016/679 and Article 5(3) of the ePrivacy Directive. Not a certification or legal assessment.
Priority findings
6 findings rated critical or high. Fix these first.
GDPR outside view
These are the privacy signals visitors and data protection authorities look for under GDPR.
Critical
EU business without adequate privacy measures
EU businesses are subject to strict GDPR requirements
What to do: Implement comprehensive GDPR compliance including privacy policy, cookie consent, and data protection measures
High
No Cookie Policy found
GDPR requires clear information about cookie usage
What to do: Add a dedicated cookie policy explaining cookie usage and purposes
This scan found 25 issues across 6 checks. Monitoring re-runs those checks daily, emails you when something material changes and records each fix, so you can show progress.
Daily monitoring
Recommended
€25per month
TLS certificates and expiry
DNS records
SPF, DKIM and DMARC
Security headers
GDPR and NIS2 posture
Exposed services
Third-party trackers
Security score drift
Email alerts on material changes and an exportable JSON history of every change.
Prices incl. 21% VAT. Secure checkout by Mollie; sold by SEQ SIA, Latvia.
Results by check
Each check with its score, findings and the evidence it collected.
How this score is calculated
The security score runs 0–100, higher is better. It is the plain average of the security checks that completed in this scan, each counted equally. A check that could not run is left out: it counts neither as a pass nor as a fail.
Counted in this score
SSL/TLS
67
Security headers
80
Email security
40
DNS health
60
Network security
100
GDPR outside view
28
Average
63
Not counted
NIS2 outside view: Re-weights evidence from the TLS, email, DNS, network and hygiene checks, so counting it would count that evidence twice. Shown on its own.
OffSeq Observations: An AI reading of the site, useful context but not reproducible evidence. Shown on its own.
Findings that cap the score at 49
Each of these is serious on its own, so while any is present the site cannot rate better than high risk, however good the other checks are.
The certificate is not trusted by browsers
The website is not served over HTTPS
A database, remote desktop, file-sharing or Telnet service is reachable from the internet
The page loads a script from a compromised source
The domain registration has expired
SPF authorises every server to send mail as the domain
Partial scans
When the site blocks Guard or most checks cannot run, the score covers only the checks that ran (usually DNS and email), is capped at 75 and is shown as partial, without a risk level.
Risk levels
Critical0–25
High26–49
Medium50–75
Low76–100
Breach exposure
Leaked credentials and lookalike domains from OffSeq Breach. The counts are free; the detailed lists are paid add-ons.
Dark web exposure
Add-on
Leaked records that mention dekade-gegen-krebs.de, from OffSeq Breach.
No leaked records found
Breach holds no records for dekade-gegen-krebs.de right now. New leaks arrive continuously, so monitoring on Breach alerts you if that changes.
Business context, site observations and technical notes gathered during the scan, and the standards behind each reference.
Business context
Business profile
The Nationale Dekade gegen Krebs occupies a leading position in Germany's healthcare and research sector as a government initiative fostering collaboration among cancer research entities, patient groups, and supporting organizations. Its business model is non-profit and publicly funded, focusing on knowledge dissemination, project funding, and stakeholder engagement. The extensive partner network includes pharmaceutical companies, research institutes, and patient advocacy groups, enhancing its influence and reach. The website's content and structure support its role as an authoritative information hub, targeting patients, researchers, and the general public. Growth indicators include active event listings, newsletters, and multimedia content. Strategic partnerships with reputable organizations strengthen its market presence and credibility.
Security posture
The website demonstrates a mature security posture with HTTPS enforced and a GDPR-compliant cookie consent banner that allows users to opt-in for anonymized statistics collection via Matomo. No exposed sensitive data or vulnerable libraries were detected in the HTML content. However, explicit security headers such as Content-Security-Policy, X-Frame-Options, and X-Content-Type-Options are not visibly implemented and should be added to enhance protection against common web attacks. Incident response and security policy information are not publicly available, which could be improved to increase transparency and readiness. Overall, the site balances user privacy and security well, with room for strengthening HTTP header configurations.
Recommendations
Implement and enforce security headers including Content-Security-Policy, X-Frame-Options, and X-Content-Type-Options.
Publish a clear security policy and incident response contact information to improve transparency and trust.
Regularly audit and update third-party libraries to mitigate potential vulnerabilities.
Enhance contact information availability for user support and security reporting.
Continue maintaining GDPR compliance and transparent cookie consent mechanisms.
Site observations
Automated reading of the public site. Ratings are indicative.
Business
Company
Nationale Dekade gegen Krebs
Description
Initiative des BMBF, vereint alle relevanten Akteure in Deutschland zur Förderung der Krebsforschung zum Wohle der Betroffenen.
Key services
Information dissemination, Research project funding and overview, Patient participation facilitation, Partner and supporter engagement, Event and publication services
Website is a German government initiative focused on cancer research.
Content is comprehensive, well-structured, and professionally presented.
Strong emphasis on privacy and cookie consent compliance.
No signs of malicious or suspicious activity.
Extensive partner and supporter network with reputable organizations.
No contact emails or phone numbers explicitly listed on homepage content.
No terms of service page detected.
Use of Matomo analytics with anonymized data collection and consent.
No advertising or affiliate marketing detected.
Technical notes
Notes
The website is built on the Government Site Builder CMS, a specialized platform for German federal administration websites, ensuring compliance with government standards. It uses modern front-end technologies including HTML5, CSS3, JavaScript, Slick Slider for carousels, and MediaElement.js for video playback. The site is mobile-optimized with responsive design and accessibility features such as ARIA labels and skip navigation links. Performance is moderate, likely due to rich multimedia content and extensive partner logos. SEO is well addressed with proper meta tags, Open Graph tags, and canonical links. Hosting is provided by ITZBund, a trusted federal IT service provider. Technical risks are minimal, but adding explicit security headers and optimizing performance could further improve robustness.
Standards and sources
Reference chips under each finding point to the standard, regulation or specification the finding relates to. They are taken from the official datasets below and mapped conservatively: a finding with no defensible link shows none. NIS2 and GDPR references mark where a finding is relevant evidence, not a compliance verdict. Implementing Regulation (EU) 2024/2690 binds digital infrastructure and digital service providers; for other entities it is the most detailed public reading of the Article 21 measures. WCAG, EN 301 549, European Accessibility Act and Web Accessibility Directive references name the requirement an automated accessibility rule relates to; they are not a conformance verdict.
Reviews of this site
Share your experience with dekade-gegen-krebs.de. Every review is verified by email and published after moderation.
Community rating
No published reviews yet. Be the first to review dekade-gegen-krebs.de.